Skip to content
healthcare.dev

ESOMEPRAZOLE MAGNESIUM

NDC 64980-664, ESOMEPRAZOLE MAGNESIUM, capsule, delayed release, from Rising Pharma Holdings, Inc..

Product NDC
64980-664
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
CAPSULE, DELAYED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA216349
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/64980-664 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ESOMEPRAZOLE MAGNESIUM20 mg/1

Pharmacologic classes

Cytochrome P450 2C19 Inhibitors [MoA]; Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]

Package NDCNDC-11Package
64980-664-19649800664193 BOTTLE in 1 CARTON (64980-664-19) / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE
64980-664-41649800664411 BOTTLE in 1 CARTON (64980-664-41) / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • NADAC price for package 64980066419

    GET /v1/drugs/nadac/64980066419

Use it

Look up 64980-664 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/64980-664 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 64980-664. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.